AGTC
Alachua · Founded 1999
About AGTC
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.
Company Facts
- Founded: 1999
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $195.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 2022)
- Ticker: nasdaq:AGTC
- Website: agtc.com
- Phone: +1 386-462-2204
Industries & Categories
Biotechnology, Clinical Trials, Genetics, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/agtc-108668 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.